IGF2 and glioblastoma: These results revealed that IGF2 is significantly upregulated in the tumors of patients with TMZ-resistant GBM and low OS, whereas IGFBP6 expression is upregulated in the tumors of patients with TMZ-sensitive GBM and longer OS.